Skip to NavigationSkip to content

News

0
Janssen's Symtuza scores approval with the FDA in HIV-1
Janssen has announced that Symtuza has received approval from the FDA in the treatment of HIV-1, making it the first and only darunavir-based single...
0
AstraZeneca increases drug stockpile in preparation for no-deal Brexit
The Anglo-Swedish drug giant AstraZeneca is set to increase its stockpile of drugs in both the United Kingdom and the European Union in preparation...
0
Novartis follows Pfizer's lead, pledges no price hikes in 2018
Following US pharma giant Pfizer’s clash with President Donald Trump after it was called out on Twitter for hiking the prices of 100 of its...
0
Researchers develop algorithm able to identify antidepressant suitability
A study published by researchers at McLean Hospital in Belmont, Massachusetts has led to the development of a statistical algorithm that is able to...
>> More News Stories

Features

Recruitment and retention: How can we do better?

In pharma R&D, data is king, but consistent struggles with patient retention is undermining the integrity of clinical findings. Matt Fellows...

>> More Features
>> More News Stories